U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07321821) titled 'Fermented Garlic Lettuce Powder and Cognitive Function in Adults With Mild Cognitive Impairment' on Dec. 23, 2025.
Brief Summary: "This study aims to investigate the cognitive and psychological changes in adults with mild cognitive impairment (K-MoCA scores between 16 and 23) following daily consumption of fermented garlic lettuce powder for 2 months
Study Start Date: Sept. 19, 2025
Study Type: INTERVENTIONAL
Condition:
Mild Cognitive Impairment (MCI)
Intervention:
DIETARY_SUPPLEMENT: Garlic Lettuce Fermented Powder
The Garlic Lettuce Fermented Powder tablets (intervention group) are taken 3 tablets daily for 2 months, totalin...